Stability Flashcards

1
Q

what is stability

A

he extent to which a dosage form retains, within specific limits, and throughout its period of storage and use (i.e. its shelf life) the same properties and characteristics that is possessed at the time of its manufacture

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what factors affect drug stabiltiy

A
  • Environmental factors:
    • temperature,
    • light,
    • humidity
    • oxygen
    • carbon dioxide
  • Dosage form factors:
    • particle size
    • pH
    • solvent system composition
    • compatibility of anions and cation
    • primary container
    • additives
    • molecular binding
    • diffusion of drugs and excipients.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

why be concerned about stabilty

A
  1. need to ensure patient receives the intended drug and dose

*Degradation will decrease concentration of API in the product

  1. prevent the appearance of contaminants or toxic compounds

*Toxic compounds can result from the degradation of either APIs or excipients

  1. exclude any decrease in bioavailability as a result of chemical or physical changes in the product

*Decrease in bioavailability will lower therapeutic effect

  1. To eliminate possibility of poor patient compliance as a result of substantial changes in appearance of product
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what is shelf life

A

The period of time which if stored correctly the productis expected

to retain acceptable chemical, physical, and microbiological stability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

expiry date

A

The date given on the product packaging which represents the end of the shelf life

– Expressed as month/year on packaging

• i.e NOV 18 – expires November 30, 2018

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Expiration condition

A

On the day of expiry drug must still retain 90% of its labeled potency

* for dry products, reconstitue at time of dispensing: exp date req for both the reconstituted and the dry prouct

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what are the types of tabiltiy

A
  • PHysical
    • viscosity, appearance, odor, colour suspendabiltiy
  • chemical
    • pH, drug content
  • microbiological
    • sterility, microbial load, preservative effectiveness
  • Therapeutic
    • activty and potency
  • Toxicological
    • identification of degradetion products
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

factors of physical stabiltiy -> what to look for

A
  • all liq products
    • sorption to drug container
    • shedding of paritcles from glass containers
    • evaporation of chloroform used as presevative
  • solutions
    • precipitation of drug or degredation products
  • Suspensions
    • caking of sediment
    • particle growth
  • Emulsions and screams
    • creaming and cracking
    • rediction in viscosity
  • Ointments
    • separation of liquid onto surface (bleeding)
  • Solid dose forms
    • phymorphic change
    • change in disintegration time of dosage form
    • chang in crushing strenght
  • Transdermal patched
    • change in drug release rate and adhesive characteristics
  • inhalation and nasal aerosols
    • change in particle size dsit and emitted dose
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what is the primary evidence os instabiltiy of capsules

A

hardening or softening

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what is the primary evidence os instabiltiy of tablets

A

powdering, chipping, mottling, discoloration and fusion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what is the primary evidence os instabiltiy of powders

A

Caking ,colorchange, swelling due to pre mature effervescent reaction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what is the primary evidence os instabiltiy of lozenges/troches

A

clumping, tackiness and dsiocoloration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

evidence of instabiltiy for solutions in general

A

clarity, precipitation mmold/bacterial growth, odor and loss of volume

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

evidence of instabiltiy for emulsions

A
  • odor, colour change, creaming, coalescence, phase separation and mold/bacterial growth
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

how can you enhance the stabilityof emulsions

A
  • dec droplet size (deal is < 5um)
  • obtain optimal ratio of water (40-60% of product volume)
  • inc viscity of external phase
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

evidence of instablilty for suspensions

A

non uniformity, caking, crystlal grwoth (precipitation), easy of resuspension, mold/bac growth, odor, loss of vol

*less susceptible to chme degredation than solutions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

vidence for instbaility for creams, grals and ointments (semisolid dosage forms)

A

Shrinking due to water evaporation, separation, discoloration,

microbial growth, grittiness.

18
Q

vidence for instbaility for suppositories

A

Glycerin and PEG suppositories are hygroscopic – protect from moisture

• Softening, crystallization (polymorphism), dry out and harden

19
Q

responsibilities of the pahrmacist for storage

A
  • dispense older stock first
  • sotre at rec conditions
  • observe for evidence of isntabiltiy
  • properly treat and lable products that are repackaged, diluted or mixed with other products
  • dispense in proper container-closure system
  • informa nd educate patients concerning proper stoage and use products including how to dispose of exp products
20
Q

what is the aim for mircobiological stability

A

To prevent the presence and growth of pathogenic microorganisms which can spoil product

21
Q

what are the souces for microbiological contamination and means to rpevent

A
  • raw materials including water
  • Manufacturing environment (atmosphere, equipment and work surfaces)

– Manufacturing Personnel

*prevent by sterilizationa nd addition of preservatives

22
Q

ranges allowed for chemical stability

A

* Chemical degradation is often the most critical parameter determining shelf-life

  • drug content of 90% of the theoretical value is considered themaximum allowable reduction
23
Q

how can you combat the degredation fo chemcial products

A

overage

  • ie make 110% conc

*only possible where degredation products are non toxic and dose is not critical

24
Q

what are the types of degredation reactions

A

– Hydrolysis

– Oxidation
– Isomerization
– Polymerization
– Photodegradation
– Chemical incompatibilities

25
Q

what chemcial groups are suspectible to hydrolysis

A

esters, amides, alctams and lactones

26
Q

what factors affect hydrolysis

A

pH, buffer salts, ionic strength, presence of co- solvents, complexing agents, surfactants.

27
Q
A
  • beta lactam ring and opens up
  • amide group on lidocaine hydrolyses and forms active
28
Q

pH and degredation

A

diff drugs stable at diff pHs

a) stable at acidic pH, b) at basic, c) stable at neutral

29
Q

what is oxidation?

what are the diff types of reaction

A
  • free radical chain reactions
  • initation is the fow step, so waht to inhibit that step or inhibit proporgation
  • Initiation:
    • X• + RH —> R• + XH
  • Propagation:
    • R• + O2 –> ROO•
    • ROO• + RH —> ROOH + R•
  • Termination:
  • ROO• + ROO• —> stable product
  • ROO• + R• –> stable product
  • R• + R• –> stable product
30
Q

oxidation examples

A
31
Q

what factors can promote oxidation

A

free readicadicals -> light or heavy metals

32
Q
A
33
Q

isomerization

A
  • many drugs depend on their isomer for activity
  • must watch for racimization and epimerization
  • important steroisomers are:
  • > Geometrical isomers (naftifine)
  • > strucutral isomers; betamethasone 17-valerate to betamethasone 21-valerate
34
Q

POLYMERIZATION

A

alos type of dimerization

35
Q

what is photodecomposition

A

photolysis

36
Q

what facotrs affect stabilization of pharmacetuics

A

temperature,

solvent

, acid base catalyiss

light

oxygen

37
Q

how to regulate affect of temp of stabiltiy

A

store product in refridgerator

38
Q

how to regulate affect of solvent of stabiltiy

A
  • replace aq solvent with a non aqueous
  • solid dosage forms are usually not stable -> sue dry powder for reconstitution suspensions
39
Q

how to regulate effect of acid base catalysis for stabilization of pharmaceuticals

A

– Control drug’s pH of maximal stability

– Use buffers

– Complexation with excipients (e.g cyclodextrins)

40
Q

how to regulate the effect of light on stabilization of pharmaceuticals

A

use containers to protect from light

41
Q

how to regualte efefcts of oxygen on stabilization of pharmaceuticals

A
  • Reduce size of containers, use single-use

– Adding antioxidants: ascorbic acid, BHA, vitamin E

– Add chelating agents (EDTA) or citric acid

– Sealing container with inert gas e.g. N2